ArticlePakistan journal of medical sciences2026
Methicillin-Resistant
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Breast abscesses are a common complication of mastitis, traditionally caused by methicillin-sensitive Methodology: A retrospective cross-sectional study was conducted at Aga Khan University Hospital, Karachi, from January 2010 to December 2024. All culture-positive breast abscesses with Results: Of 366 culture-positive breast abscesses, 326 (89.0%) yielded Conclusion: This study reports one of the highest documented MRSA prevalence rates (74.5%) in breast abscesses worldwide, with a clear post-2020 dominance. Despite high MRSA burden, excellent outcomes were achieved with ultrasound-guided drainage and susceptibility-guided antibiotics. In high-prevalence settings, empirical therapy must cover MRSA, and routine culture with sensitivity testing is strongly recommended. Ultrasound-guided aspiration should remain first-line management, and continued breastfeeding is safe and encouraged after treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.